1. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005; 111:e394–e434.
2. Walker KA, Sampson JB, Skalabrin EJ, Majersik JJ. Clinical Characteristics and Thrombolytic Outcomes of Infective Endocarditis-Associated Stroke. Neurohospitalist. 2012; 2:87–91.
3. Kan P, Webb S, Siddiqui AH, Levy EI. First reported use of retrievable stent technology for removal of a large septic embolus in the middle cerebral artery. World Neurosurg. 2012; 77:591.e1–591.e5.
4. Sukumaran S, Jayadevan ER, Mandilya A, Sreedharan SE, Harikrishnan S, Radhakrishnan N, Sylaja PN. Successful mechanical thrombectomy of acute middle cerebral artery occlusion due to vegetation from infective endocarditis. Neurol India. 2012; 60:239–240.
5. Dababneh H, Hedna VS, Ford J, Taimeh Z, Peters K, Mocco J, Waters MF. Endovascular intervention for acute stroke due to infective endocarditis: case report. Neurosurg Focus. 2012; 32:E1.
6. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003; 34:e109–e137.
7. Bhuva P, Kuo SH, Claude Hemphill J, Lopez GA. Intracranial hemorrhage following thrombolytic use for stroke caused by infective endocarditis. Neurocrit Care. 2010; 12:79–82.
8. Heiro M, Nikoskelainen J, Engblom E, Kotilainen E, Marttila R, Kotilainen P. Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med. 2000; 160:2781–2787.
9. Jenkinson HF, Lamont RJ. Oral microbial communities in sickness and in health. Trends Microbiol. 2005; 13:589–595.
10. Douglas CW, Heath J, Hampton KK, Preston FE. Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol. 1993; 39:179–182.
11. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006; 37:2094–2099.
12. Sila C. Anticoagulation should not be used in most patients with stroke with infective endocarditis. Stroke. 2011; 42:1797–1798.
13. Gillinov AM, Shah RV, Curtis WE, Stuart RS, Cameron DE, Baumgartner WA, Greene PS. Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg. 1996; 61:1125–1129.
14. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012; 366:2466–2473.